Rapamycin causes regression of astrocytomas in tuberous sclerosis complex
- PMID: 16453317
- DOI: 10.1002/ana.20784
Rapamycin causes regression of astrocytomas in tuberous sclerosis complex
Abstract
Objective: Tuberous sclerosis complex (TSC) is a genetic disorder characterized by the formation of hamartomas in multiple organs. Five to 15% of affected individuals display subependymal giant cell astrocytomas, which can lead to substantial neurological and postoperative morbidity due to the production of hydrocephalus, mass effect, and their typical location adjacent to the foramen of Monro. We sought to see whether therapy with oral rapamycin could affect growth or induce regression in astrocytomas associated with TSC.
Methods: Five subjects with clinically definite TSC and either subependymal giant cell astrocytomas (n = 4) or a pilocytic astrocytoma (n = 1) were treated with oral rapamycin at standard immunosuppressive doses (serum levels 5-15 ng/ml) from 2.5 to 20 months. All lesions demonstrated growth on serial neuroimaging studies. Magnetic resonance imaging scans were performed before and at regular intervals following initiation of therapy.
Results: All lesions exhibited regression and, in one case, necrosis. Interruption of therapy resulted in regrowth of subependymal giant cell astrocytomas in one patient. Resumption of therapy resulted in further regression. Treatment was well tolerated.
Interpretation: Oral rapamycin therapy can induce regression of astrocytomas associated with TSC and may offer an alternative to operative therapy of these lesions.
Similar articles
-
Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex.J Neurosurg Pediatr. 2010 Oct;6(4):381-4. doi: 10.3171/2010.7.PEDS10221. J Neurosurg Pediatr. 2010. PMID: 20887114
-
Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.Pediatr Neurol. 2013 Dec;49(6):439-44. doi: 10.1016/j.pediatrneurol.2013.08.017. Epub 2013 Oct 15. Pediatr Neurol. 2013. PMID: 24138953
-
[Subependymal giant cell astrocytoma in tuberous sclerosis complex. A presentation of eight paediatric patients].Neurologia. 2010 Jun;25(5):314-21. Neurologia. 2010. PMID: 20643042 Spanish.
-
Rapamycin and rapalogs for tuberous sclerosis complex.Cochrane Database Syst Rev. 2016 Jul 13;7(7):CD011272. doi: 10.1002/14651858.CD011272.pub2. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2023 Jul 11;7:CD011272. doi: 10.1002/14651858.CD011272.pub3. PMID: 27409709 Free PMC article. Updated. Review.
-
Neonatal subependymal giant cell astrocytoma: new case and review of literature.Pediatr Neurol. 2007 Feb;36(2):128-31. doi: 10.1016/j.pediatrneurol.2006.08.009. Pediatr Neurol. 2007. PMID: 17275668 Review.
Cited by
-
Radiotherapy for subependymal giant cell astrocytoma: time to challenge a historical ban? A case report and review of the literature.J Med Case Rep. 2024 Jul 20;18(1):330. doi: 10.1186/s13256-024-04649-2. J Med Case Rep. 2024. PMID: 39030575 Free PMC article. Review.
-
Perinatal Results and Long-Term Follow-Up of Fetal Cardiac Tumors: A 30-Year Historical Cohort Study.Arq Bras Cardiol. 2024 Mar 22;121(1):e20220469. doi: 10.36660/abc.20220469. eCollection 2024. Arq Bras Cardiol. 2024. PMID: 38536996 Free PMC article. English, Portuguese.
-
A Stable Micellar Formulation of RAD001 for Intracerebroventricular Delivery and the Treatment of Alzheimer's Disease and Other Neurological Disorders.Int J Mol Sci. 2023 Dec 14;24(24):17478. doi: 10.3390/ijms242417478. Int J Mol Sci. 2023. PMID: 38139306 Free PMC article.
-
Rapamycin and rapalogs for tuberous sclerosis complex.Cochrane Database Syst Rev. 2023 Jul 11;7(7):CD011272. doi: 10.1002/14651858.CD011272.pub3. Cochrane Database Syst Rev. 2023. PMID: 37432030 Free PMC article. Review.
-
Phase II study of everolimus for recurrent or progressive pediatric ependymoma.Neurooncol Adv. 2023 Feb 10;5(1):vdad011. doi: 10.1093/noajnl/vdad011. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 36950217 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical